Advertisement
News
Subscribe to MDT Magazine News

Nordstrom Announces 2011 Black History Month Initiative

February 1, 2011 7:36 am | by Bio-Medicine.Org | Comments

SEATTLE, Feb. 1, 2011 /- Nordstrom, Inc. announced today that it is recognizing Black History Month in 2011 by teaming up with Be The Match® to help raise awareness of the critical need for more African American marrow and umbilical cord blood donors. As part of its "Living Well"...

TOPICS:

ERT to Present at the UBS 21st Annual Global Healthcare Services Conference on February 7, 2011

February 1, 2011 7:34 am | by Bio-Medicine.Org | Comments

PHILADELPHIA, Feb. 1, 2011 /- ERT (Nasdaq: ERES ), announced today that Keith Schneck, the Company's Chief Financial Officer, is scheduled to present at the UBS 21st Annual Global Healthcare Services Conference at 8:00 AM EST on February 7, 2011 in New York City. Interested...

TOPICS:

With Healthcare Reform, Be Careful What You Wish For

February 1, 2011 7:34 am | by Diagnostic Imaging | Comments

For those who want to overturn the law, the real risk is that in the longer term it sets up the likelihood of a single-payer system. In my opinion, by making the fines less than the cost of the insurance, it leaves a way for companies to not insure their employees. So it automatically...

TOPICS:
Advertisement

Reportlinker Adds Personalized Medicine - Scientific & Commercial Aspects

February 1, 2011 7:33 am | by Bio-Medicine.Org | Comments

NEW YORK, Feb. 1, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: Personalized Medicine - scientific & commercial aspects http://www.reportlinker.com/p0203549/Personalized-Medicine---scientific--commercial-aspects.html Summary The...

TOPICS:

Race gap narrows for some cancers in African-Americans; continues to increase for others

February 1, 2011 6:38 am | by EurekAlert | Comments

(American Cancer Society) While the overall death rate for cancer continues to drop among African-Americans, the group continues to have higher death rates and shorter survival of any racial and ethnic group in the US for most cancers. The findings come from Cancer Facts & Figures...

TOPICS:

Genzyme closes $265M unit sale, plans another divestiture

February 1, 2011 6:35 am | by Mass High Tech: The Journal of New England Technology | Comments

Genzyme Corp. plans to sell its pharmaceutical intermediates business to an affiliate of the International Chemical Investors Group. Today's news comes as the Cambridge biotech giant completes its $265 million cash sale of its diagnostics business to Sekisui Chemical Co, Ltd., announced...

Soligenix Appoints Kevin Horgan, MD, as Chief Medical Officer

February 1, 2011 6:32 am | by Bio-Medicine.Org | Comments

PRINCETON, N.J., Feb. 1, 2011 /- Soligenix, Inc. (OTC Bulletin Board: SNGX ) (Soligenix or the Company), a late-stage biopharmaceutical company, announced today that it has appointed Kevin Horgan, MD, as its Senior Vice President and Chief Medical Officer. Dr. Horgan is a board-certified...

TOPICS:

Quest Diagnostics Announces Pricing in Offering of Common Stock by the Company's Largest Shareholder

February 1, 2011 6:31 am | by Bio-Medicine.Org | Comments

MADISON, N.J., Feb. 1, 2011 /- Quest Diagnostics Incorporated (NYSE: DGX ) today announced the pricing of the previously announced secondary public offering of 15,377,600 shares of Quest Diagnostics common stock held by its largest stockholder, SB Holdings Capital Inc., an affiliate of...

TOPICS:
Advertisement

Biogen 4Q profit drops 21 pct as expenses rise

February 1, 2011 5:45 am | by The Associated Press | Comments

The biotechnology company Biogen Idec reported that its fourth-quarter profit tumbled 21 percent, citing on Tuesday restructuring charges and rising expenses that outweighed the sales of key drugs.The performance topped expectations on Wall Street and shares rose 3 percent..The Weston, Mass.,...

Massachusetts Sen. Brown urges medical device tax repeal

February 1, 2011 5:34 am | by Mass High Tech: The Journal of New England Technology | Comments

As Congressional Republicans ready their assault on President Barack Obama's health care reform law, Bay State Sen. Scott Brown said Monday that he would file legislation to chip away at the bill by repealing the medical device tax that he said will stymie job growth in Massachusetts.

Discovery Labs targets 3Q for Surfaxin FDA filing

February 1, 2011 4:45 am | by The Associated Press | Comments

Discovery Laboratories Inc. said Tuesday it aims to file early in the third quarter a complete response to the Food and Drug Administration for its drug Surfaxin.Surfaxin aims to prevent respiratory distress syndrome in premature infants. The Warrington, Pa., company said it believes a key...

Canada's Windsor-Essex Region Collaborates With IBM to Improve Quality of Life for Citizens

February 1, 2011 4:35 am | by IBM | Comments

The region of Windsor-Essex, Ontario, Canada, today announced that it is using social business technology from IBM (NYSE: IBM) to significantly improve the quality of life for its citizens. E-mail this page Save to del.icio.us Digg this

TOPICS:

UBM Studios Virtual Event Connects the UBM Canon Medical Device Media Group with the Medical Device Design Community

February 1, 2011 4:35 am | by Bio-Medicine.Org | Comments

CHICAGO, Feb. 1, 2011 /- UBM Canon Medical Device Media Group's MD+DI , MPMN and OrthoTec presented the " Technological Advances in Implantable Devices " virtual event on January 26, 2011 from 11 a.m. – 5 p.m. Eastern.  The event is dedicated to cutting-edge trends in the...

TOPICS:

CardioGenics to Continue Commercialization of its Magnetic Beads with Merck Chimie SAS

February 1, 2011 4:35 am | by Bio-Medicine.Org | Comments

MISSISSAUGA, Ontario, Feb.  1, 2011 /- CardioGenics Holdings Inc. (OTC Bulletin Board: CGNH ) announced today that CardioGenics and Merck Chimie SAS continue the commercialization process of CardioGenics' magnetic beads. Merck recently notified CardioGenics that while it is refining...

TOPICS:

CryoLife Announces Release Date and Teleconference Call Details for 2010 Fourth Quarter and Year End Financial Results

February 1, 2011 4:34 am | by Bio-Medicine.Org | Comments

ATLANTA, Feb. 1, 2011 /- CryoLife, Inc. (NYSE: CRY ), an implantable biological medical device and cardiovascular tissue processing company, announced today that 2010 fourth quarter and year end financial results will be released on Thursday, February 17, 2011.  On that day, the...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading